Financial News
Inmune Bio Inc (NQ: INMB )
6.950
+0.500
(+7.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Inmune Bio Inc
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
INmune Bio: Q4 Earnings Insights
March 28, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
A Preview Of INmune Bio's Earnings
March 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
From INmune Bio, Inc.
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/doctor-3822863-1280.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/54cf5f33-04a3-4013-9a56-65d021e46a21/small/800-px-horizontal-logo-png.png)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.